VAD Use Beyond Sickest Patient Population Expected Soon, Experts Agree
This article was originally published in The Gray Sheet
Executive Summary
Ventricular assist technology for patients healthier than those targeted in the pivotal REMATCH trial will be available within the next three years, Mehmet Oz, Columbia University College of Physicians and Surgeons, predicted on March 17